These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 9889441)

  • 1. Correlates of retention on the South Australian Methadone Program 1981-91.
    Gaughwin M; Solomon P; Ali R
    Aust N Z J Public Health; 1998 Dec; 22(7):771-6. PubMed ID: 9889441
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictors of outcome in methadone programs: effect of HIV counseling and testing.
    Farley TA; Cartter ML; Wassell JT; Hadler JL
    Conn Med; 1994 Mar; 58(3):165-71. PubMed ID: 8039381
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does HIV test result influence methadone maintenance treatment retention?
    Wimbush J; Amicarelli A; Stein MD
    J Subst Abuse; 1996; 8(2):263-9. PubMed ID: 8880665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A longitudinal comparison of retention in buprenorphine and methadone treatment for opioid dependence in New South Wales, Australia.
    Burns L; Gisev N; Larney S; Dobbins T; Gibson A; Kimber J; Larance B; Mattick RP; Butler T; Degenhardt L
    Addiction; 2015 Apr; 110(4):646-55. PubMed ID: 25516077
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Who uses methadone services in China? Monitoring the world's largest methadone programme.
    Sullivan SG; Wu Z; Rou K; Pang L; Luo W; Wang C; Cao X; Yin W; Liu E; Mi G;
    Addiction; 2015 Jan; 110 Suppl 1():29-39. PubMed ID: 25533862
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retention in Georgia opioid substitution therapy program and associated factors.
    Ruadze E; Todadze K
    Harm Reduct J; 2016 Dec; 13(1):35. PubMed ID: 27931232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retention rate and illicit opioid use during methadone maintenance interventions: a meta-analysis.
    Farré M; Mas A; Torrens M; Moreno V; Camí J
    Drug Alcohol Depend; 2002 Feb; 65(3):283-90. PubMed ID: 11841899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dose-response relationship between methadone dose and adherence to antiretroviral therapy among HIV-positive people who use illicit opioids.
    Lappalainen L; Nolan S; Dobrer S; Puscas C; Montaner J; Ahamad K; Dong H; Kerr T; Wood E; Milloy MJ
    Addiction; 2015 Aug; 110(8):1330-9. PubMed ID: 25940906
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Methadone treatment of narcotic addicts--can it be justified?].
    Sundby P
    Tidsskr Nor Laegeforen; 1991 Oct; 111(25):3056. PubMed ID: 1948915
    [No Abstract]   [Full Text] [Related]  

  • 10. Client retention in the British Columbia Methadone Program, 1996-1999.
    Anderson JF; Warren LD
    Can J Public Health; 2004; 95(2):104-9. PubMed ID: 15074899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dose-response effects of methadone in the treatment of opioid dependence.
    Strain EC; Stitzer ML; Liebson IA; Bigelow GE
    Ann Intern Med; 1993 Jul; 119(1):23-7. PubMed ID: 8498759
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcomes of an AIDS prevention program for methadone patients.
    Magura S; Siddiqi Q; Shapiro J; Grossman JI; Lipton DS; Marion IJ; Weisenfeld L; Amann KR; Koger J
    Int J Addict; 1991 Jun; 26(6):629-55. PubMed ID: 1757169
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of ongoing illicit drug use on methadone adherence in illicit drug users receiving treatment for HIV in a directly observed therapy program.
    Raffa JD; Grebely J; Tossonian H; Wong T; Viljoen M; Khara M; Mead A; McLean M; Duncan F; Petkau AJ; DeVlaming S; Conway B
    Drug Alcohol Depend; 2007 Jul; 89(2-3):306-9. PubMed ID: 17383117
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patterns of abstinence or continued drug use among methadone maintenance patients and their relation to treatment retention.
    White WL; Campbell MD; Spencer RD; Hoffman HA; Crissman B; DuPont RL
    J Psychoactive Drugs; 2014; 46(2):114-22. PubMed ID: 25052787
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How clients' during-treatment motivations relate to their perceptions and impressions of methadone maintenance treatment: A multilevel analysis of a cross-sectional survey in Guangdong Province, China.
    Deng L; Zou X; Chen W; Xia Y; Liu Y; Ling L
    Drug Alcohol Depend; 2016 Jul; 164():151-157. PubMed ID: 27230725
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact on retention of expansion of an Australian public methadone program.
    Bammer G; Battisson L; Ward J; Wilson S
    Drug Alcohol Depend; 2000 Feb; 58(1-2):173-80. PubMed ID: 10669069
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors of early dropout in methadone maintenance treatment program in Yunnan province, China.
    Che Y; Assanangkornchai S; McNeil E; Chongsuvivatwong V; Li J; Geater A; You J
    Drug Alcohol Rev; 2010 May; 29(3):263-70. PubMed ID: 20565518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retention, HIV risk, and illicit drug use during treatment: methadone dose and visit frequency.
    Rhoades HM; Creson D; Elk R; Schmitz J; Grabowski J
    Am J Public Health; 1998 Jan; 88(1):34-9. PubMed ID: 9584030
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contingent methadone delivery: effects on illicit-opiate use.
    Higgins ST; Stitzer ML; Bigelow GE; Liebson IA
    Drug Alcohol Depend; 1986 Jul; 17(4):311-22. PubMed ID: 3757767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methadone dosage and retention: an examination of the 60 mg/day threshold.
    Brady TM; Salvucci S; Sverdlov LS; Male A; Kyeyune H; Sikali E; DeSale S; Yu P
    J Addict Dis; 2005; 24(3):23-47. PubMed ID: 16186081
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.